Does Dr. JOSE ACEVEDO ECHEVARRIA have financial conflicts of interest?

Dr. JOSE ACEVEDO ECHEVARRIA (MD) has received a total of $152 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $152 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JOSE ACEVEDO ECHEVARRIA?

According to CMS Open Payments data, Dr. JOSE ACEVEDO ECHEVARRIA received funding from ACTELION PHARMACEUTICALS US ($79), SANOFI PASTEUR ($28), and UNITED THERAPEUTICS CORPORATION ($27).

Does Dr. JOSE ACEVEDO ECHEVARRIA receive research grants or speaking fees?

Dr. JOSE ACEVEDO ECHEVARRIA has received $152 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JOSE ACEVEDO ECHEVARRIA

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: MOBILE, AL 36617

NPI Number: 1205495520

LIFETIME INDUSTRY VALUE

$152

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ACEVEDO ECHEVARRIA is a verified Internal Medicine practitioner based in MOBILE, AL.

Between 2021 and 2025, Dr. ACEVEDO ECHEVARRIA had an overall industry promotional and research financial footprint of $152 as recorded in the federal CMS Open Payments database.

$152 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ACEVEDO ECHEVARRIA's primary funding source is ACTELION PHARMACEUTICALS US, which accounts for $79 (representing 52.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ACTELION PHARMACEUTICALS US

Rank 1

$79

52.1%

SANOFI PASTEUR

Rank 2

$28

18.1%

UNITED THERAPEUTICS CORPORATION

Rank 3

$27

17.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.